# A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

> **NCT06427590** · PHASE1 · COMPLETED · sponsor: **Ascletis Pharma (China) Co., Limited** · enrollment: 28 (actual)

## Conditions studied

- Chronic Weight Management

## Interventions

- **DRUG:** ASC47
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT06427590
- **Lead sponsor:** Ascletis Pharma (China) Co., Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427590, "A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06427590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*